Table 2.
Examples of recent studies on A7R-modified nanoparticles.
| Carrier | Therapeutic agent | Compound | Experimental model | Results | Refs. |
|---|---|---|---|---|---|
| Hybrid Silica Nanoparticle | Chlorin (photosensitizer) | A7R-HS-NP/TPC | Glioma-bearing rat model | A positive magnetic resonance imaging (MRI) contrast and intratumoral retention were increased greatly. | [78], [79], [80] |
| Superparamagnetic iron oxide-based nanoparticles | Ni0.5Zn0.5Fe2O4 | A7R-SPIONs/Fe | HUVEC (endothelial cells) | The cell viability of HUVEC was reduced. | [84] |
| Nanoparticles | Paclitaxel | A7R-CGKRKR-NP/PTX | U87MG glioblastoma | Apoptosis induction and anti-proliferative activity were enhanced. | [87] |